GlassScriptPhysician profile
Burhan Yanes
NPI 1275572869
$14,216.71
in general payments reported to CMS, 2019-2025
74 companies · $4,095 in 2025
The $4,095 reported for 2025 was more than what 79% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $154 · 2021: $1,888 · 2022: $2,705 · 2023: $1,932 · 2024: $2,957 · 2025: $4,095.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,412 · Consulting Fee: $2,910 · Travel and Lodging: $359 · Education: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,412.07 |
| Consulting Fee | $2,910.00 |
| Travel and Lodging | $358.55 |
| Education | $303.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $3,302.19 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $3,105.37 | 2021-2025 | Imfinzi, Calquence, Enhertu |
| Novartis Pharmaceuticals Corporation | $793.78 | 2019-2025 | |
| Daiichi Sankyo INC. | $769.09 | 2019-2025 | Enhertu, Enhertu, Injectafer |
| Merck Sharp & Dohme LLC | $638.47 | 2022-2025 | Keytruda, Welireg, Reblozyl |
| Janssen Biotech, INC. | $363.19 | 2019-2025 | Darzalex, Tecvayli, Erleada |
| Celgene Corporation | $333.36 | 2021-2025 | Pomalyst, Reblozyl, Opdivo |
| Incyte Corporation | $301.23 | 2021-2025 | Jakafi, Monjuvi, Pemazyre |
| Glaxosmithkline, LLC. | $274.57 | 2023-2025 | Ojjaara, Blenrep, Shingrix |
| Abbvie INC. | $264.37 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $245.19 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Takeda Pharmaceuticals U.S.A., INC. | $230.96 | 2021-2024 | Ninlaro, Alunbrig |
| Gilead Sciences, INC. | $209.13 | 2023-2025 | Trodelvy |
| Eisai INC. | $187.82 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $173.57 | 2019-2025 |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $172.61 | 2020-2025 | |
| Astellas Pharma US INC | $168.06 | 2020-2025 | Xtandi, Padcev, Xospata |
| Alexion Pharmaceuticals, INC. | $164.27 | 2023-2025 | Soliris, Ultomiris |
| Regeneron Healthcare Solutions, INC. | $152.18 | 2019-2025 | Libtayo, Lynozyfic |
| Emd Serono, INC. | $108.12 | 2023-2024 | Bavencio |
| Amgen INC. | $106.09 | 2020-2023 | Lumakras, Kyprolis |
| Octapharma USA, INC. | $98.19 | 2023-2025 | Octagam Immune Globulin (Human), Panzyga |
| Karyopharm Therapeutics INC. | $95.20 | 2020-2023 | Xpovio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.07 | 2019-2023 | Gilotrif |
| Kite Pharma, INC. | $88.88 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $83.31 | 2022-2024 | Onivyde, Somatuline Depot, Tazverik |
| Genmab U.S., INC. | $80.34 | 2022-2025 | Tivdak |
| Lilly USA, LLC | $79.40 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Springworks Therapeutics, INC. | $77.10 | 2025 | Ogsiveo |
| Tg Therapeutics, INC. | $75.51 | 2021 | |
| Stemline Therapeutics INC. | $73.85 | 2023-2025 | Orserdu |
| Myriad Genetic Laboratories, INC. | $70.00 | 2023 | Myrisk |
| Rigel Pharmaceuticals, INC. | $69.30 | 2019-2024 | Tavalisse, Rezlidhia |
| Genentech USA, INC. | $68.39 | 2021-2024 | Columvi, Polivy, Lunsumio |
| Seagen INC. | $58.87 | 2022-2023 | Padcev, Tukysa |
| Pharmacosmos Therapeutics INC. | $55.90 | 2024-2025 | Monoferric |
| Taiho Oncology, INC. | $52.96 | 2023-2024 | |
| Foundation Medicine, INC. | $51.39 | 2019-2023 | |
| Deciphera Pharmaceuticals INC. | $49.59 | 2022-2025 | Qinlock, Romvimza |
| Beigene USA, INC. | $48.59 | 2022-2024 | Tevimbra |
| Aveo Pharmaceuticals, INC. | $43.76 | 2025 | |
| Mirati Therapeutics, INC. | $42.55 | 2023-2024 | Krazati |
| Tersera Therapeutics LLC | $39.88 | 2025 | Xermelo |
| Pharmaessentia USA Corporation | $38.63 | 2023-2024 | Besremi |
| Array Biopharma INC | $37.83 | 2019 | |
| Immunocore Limited | $36.37 | 2024 | Kimmtrak |
| Sumitomo Pharma America, INC. | $32.29 | 2023-2024 | Orgovyx |
| Tempus Ai, INC | $31.42 | 2024-2025 | Xt Cdx |
| Morphosys, US INC. | $29.51 | 2023 | Monjuvi |
| Lexicon Pharmaceuticals, INC. | $28.51 | 2019 | |
| Servier Pharmaceuticals LLC | $26.88 | 2022 | |
| Janssen Scientific Affairs, LLC | $24.15 | 2019 | |
| Verastem, INC. | $21.87 | 2019 | |
| Aadi Bioscience, INC. | $21.52 | 2022 | |
| Apellis Pharmaceuticals, INC. | $20.00 | 2023 | Empaveli |
| Exelixis INC. | $19.45 | 2024 | Cabometyx |
| Fennec Pharmaceuticals, INC. | $19.28 | 2024 | Pedmark |
| Clovis Oncology, INC. | $18.62 | 2019 | |
| Mylan Institutional INC. | $18.35 | 2023 | Fulphila, Ogivri |
| Blueprint Medicines Corporation | $18.00 | 2025 | Ayvakit |
| Pharmacyclics LLC, An Abbvie Company | $18.00 | 2022 | |
| Tolmar, INC. | $17.91 | 2023 | |
| Adaptive Biotechnologies Corporation | $17.16 | 2024 | Clonoseq |
| Legend Biotech USA INC. | $16.98 | 2024 | |
| Sobi, INC | $16.63 | 2023 | |
| Adc Therapeutics America, INC. | $15.98 | 2023 | |
| Kyowa Kirin, INC. | $15.91 | 2023 | Poteligeo |
| Sirtex Medical INC | $15.79 | 2024 | Sir-Spheres Microspheres |
| Syndax Pharmaceuticals, INC. | $15.29 | 2025 | |
| Cti Biopharma Corp. | $14.82 | 2023 | Vonjo |
| Sun Pharmaceutical Industries INC. | $13.68 | 2023 | Yonsa, Odomzo |
| Puma Biotechnology, INC. | $13.67 | 2021 | |
| Amneal Pharmaceuticals LLC | $13.40 | 2024 | Avastin |
| Immunitybio, INC. | $13.16 | 2024 |
Drugs and devices associated with these payments
Enhertu $629Keytruda $524Imfinzi $475Ojjaara $246Epkinly $229Welireg $201Darzalex $190Reblozyl $165Imbruvica $158Jakafi $146Trodelvy $128Scemblix $126Pluvicto $125Monjuvi $108Soliris $95.95Opdivo $94.28Libtayo $91.13Kisqali $87.16Pomalyst $85.93Tecvayli $84.33Nubeqa $83.53Octagam Immune Globulin (Human) $77.68Ogsiveo $77.10Orserdu $73.85Gilotrif $73.73Erleada $73.50Myrisk $70.00Ibrance $69.72Ultomiris $68.32Lenvima $68.31Vitrakvi $67.58Stivarga $67.58Jaypirca $62.83Verzenio $62.83Tivdak $60.43Pemazyre $60.27Opdualag $60.00Balversa $56.50Xofigo $56.34Krazati $56.27Promacta $56.22Monoferric $55.90Injectafer $55.47Lonsurf $52.96Inqovi $52.96Xpovio $52.69Xtandi $50.24Fabhalta $49.87Venclexta $49.84Elrexfio $48.21Adcetris $48.21Bavencio $46.66Talvey $43.85Retevmo $43.83Fotivda $43.76Rezlidhia $43.00Tavalisse $43.00Akeega $42.70Lutathera $41.53Padcev $41.45Xermelo $39.88Besremi $38.63Kimmtrak $36.37Onivyde $34.90Somatuline Depot $34.90Tazverik $33.95Orgovyx $32.29Qinlock $32.00Carvykti $28.91Ninlaro $28.22Keytruda Qlex $26.25Lynparza $26.20Jevtana $22.49Alunbrig $22.48Datroway $21.03Lunsumio $20.99Columvi $20.99Polivy $20.99Tevimbra $20.91Panzyga $20.51Calquence $20.50Bosulif $20.09Empaveli $20.00Cabometyx $19.45Pedmark $19.28Fulphila $18.35Ogivri $18.35Lumakras $18.33Zynyz $18.12Mekinist $18.09Lynozyfic $18.02Ayvakit $18.00Eligard $17.91Clonoseq $17.16Doptelet $16.63Xospata $16.58Sarclisa $16.32Xt Cdx $16.13Poteligeo $15.91Sir-Spheres Microspheres $15.79
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Burhan Yanes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.